Chemours Co Stockholders Equity

• Chemours Co showed a decrease of -8.8% in Stockholders Equity from 2025 to 2025.
• This data is from Chemours Co's annual report (Form 10-K), filed with the SEC on February 24, 2026.
• XBRL data for this metric is available from 2014 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2015: $401.00 million | Q3 2015: $86.00 million | Q1 2016: $188.00 million | Q2 2016: $165.00 million | Q3 2016: $377.00 million | Q1 2017: $353.00 million | Q2 2017: $567.00 million | Q3 2017: $800.00 million | Q1 2018: $997.00 million | Q2 2018: $1.02 billion | Q3 2018: $1.14 billion | Q1 2019: $810.00 million | Q2 2019: $823.00 million | Q3 2019: $837.00 million | Q1 2020: $655.00 million | Q2 2020: $657.00 million | Q3 2020: $732.00 million | Q1 2021: $850.00 million | Q2 2021: $898.00 million | Q3 2021: $998.00 million | Q1 2022: $1.17 billion | Q2 2022: $1.21 billion | Q3 2022: $1.28 billion | Q1 2023: $1.23 billion | Q2 2023: $808.00 million | Q3 2023: $755.00 million | Q1 2024: $753.00 million | Q2 2024: $714.00 million | Q3 2024: $643.00 million.
• Over the full 15 years of available data (2014 to 2025), Chemours Co's Stockholders Equity has declined by 93.2%.
• Historical annual values: Fiscal year 2025: $250.00 million | Fiscal year 2025: $274.00 million | Fiscal year 2025: $228.00 million | Fiscal year 2025: $566.00 million | Fiscal year 2024: $571.00 million | Fiscal year 2023: $721.00 million | Fiscal year 2022: $1.11 billion | Fiscal year 2021: $1.08 billion | Fiscal year 2020: $813.00 million | Fiscal year 2019: $689.00 million | Fiscal year 2018: $1.01 billion | Fiscal year 2017: $860.00 million | Fiscal year 2016: $100.00 million | Fiscal year 2015: $126.00 million | Fiscal year 2014: $3.67 billion.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026